Nouvelles publications

Passet, M., Kim, R., Gachet, S., Sigaux, F., Chaumeil, J., Galland, A., Sexton, T., Quentin, S., Hernandez, L., Larcher, L., Bergugnat, H., Ye, T., Karasu, N., Caye-Eude, A., Heizmann, B., Duluc, I., Chevallier, P., Rousselot, P., Huguet, F., … Clappier, E. (2022). Concurrent CDX2 cis-deregulation and UBTF-ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL. Blood, blood.2021014723.
Bersuder, E., Terciolo, C., Lechevrel, M., Martin, E., Quesnelle, C., Freund, J.-N., Reimund, J.-M., & Gross, I. (2022). Mesalazine initiates an anti-oncogenic β-catenin / MUCDHL negative feed-back loop in colon cancer cells by cell-specific mechanisms. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 146, 112543.
Delhorme, J.-B., Bersuder, E., Terciolo, C., Vlami, O., Chenard, M.-P., Martin, E., Rohr, S., Brigand, C., Duluc, I., Freund, J.-N., & Gross, I. (2022). CDX2 controls genes involved in the metabolism of 5-fluorouracil and is associated with reduced efficacy of chemotherapy in colorectal cancer. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 147, 112630.
Sirakov, M., & Plateroti, M. (2022). Thyroid Hormone Signaling and Function: News from Classical and Emerging Models. Cells, 11(3), 453.
Priya, S., Kaur, E., Kulshrestha, S., Pandit, A., Gross, I., Kumar, N., Agarwal, H., Khan, A., Shyam, R., Bhagat, P., Prabhu, J. S., Nagarajan, P., Deo, S. V. S., Bajaj, A., Freund, J.-N., Mukhopadhyay, A., & Sengupta, S. (2021). CDX2 inducible microRNAs sustain colon cancer by targeting multiple DNA damage response pathway factors. Journal of Cell Science, 134(15), jcs258601.
Frau, C., Jamard, C., Delpouve, G., Guardia, G. D. A., Machon, C., Pilati, C., Nevé, C. L., Laurent-Puig, P., Guitton, J., Galante, P. A. F., Penalva, L. O., Freund, J.-N., de la Fouchardiere, C., & Plateroti, M. (2021). Deciphering the Role of Intestinal Crypt Cell Populations in Resistance to Chemotherapy. Cancer Research, 81(10), 2730–2744.
Galland, A., Gourain, V., Habbas, K., Güler, Y., Martin, E., Ebel, C., Tavian, M., Vallat, L., Chenard, M.-P., Mauvieux, L., Freund, J.-N., Duluc, I., & Domon-Dell, C. (2021). CDX2 expression in the hematopoietic lineage promotes leukemogenesis via TGFβ inhibition. Molecular Oncology.
Schleiss, C., Carapito, R., Fornecker, L.-M., Muller, L., Paul, N., Tahar, O., Pichot, A., Tavian, M., Nicolae, A., Miguet, L., Mauvieux, L., Herbrecht, R., Cianferani, S., Freund, J.-N., Carapito, C., Maumy-Bertrand, M., Bahram, S., Bertrand, F., & Vallat, L. (2021). Temporal multiomic modeling reveals a B-cell receptor proliferative program in chronic lymphocytic leukemia. Leukemia, 35(5), 1463–1474.
Julien, E., Biasch, K., El Omar, R., Freund, J.-N., Gachet, C., Lanza, F., & Tavian, M. (2021). Renin-angiotensin system is involved in embryonic emergence of hematopoietic stem/progenitor cells. Stem Cells (Dayton, Ohio), 39(5), 636–649.
Godart, M., Frau, C., Farhat, D., Giolito, M. V., Jamard, C., Le Nevé, C., Freund, J.-N., Penalva, L. O., Sirakov, M., & Plateroti, M. (2021). Murine intestinal stem cells are highly sensitive to modulation of the T3/TRα1-dependent pathway. Development (Cambridge, England), 148(8), dev194357.
El Omar, R., Julien, E., Biasch, K., Guffroy, B., Lioure, B., Vallat, L., Gross, I., Domon-Dell, C., Lanza, F., Gachet, C., Negroni, M., Freund, J.-N., & Tavian, M. (2021). CDX2 regulates ACE expression in blood development and leukemia cells. Blood Advances, 5(7), 2012–2016.
Giolito, M. V., Claret, L., Frau, C., & Plateroti, M. (2021). A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells. JoVE (Journal of Visualized Experiments), 167, e61783.
Baroni, M., Yi, C., Choudhary, S., Lei, X., Kosti, A., Grieshober, D., Velasco, M., Qiao, M., Burns, S. S., Araujo, P. R., DeLambre, T., Son, M. Y., Plateroti, M., Ferreira, M. A. R., Hasty, P., & Penalva, L. O. F. (2021). Musashi1 Contribution to Glioblastoma Development via Regulation of a Network of DNA Replication, Cell Cycle and Division Genes. Cancers, 13(7), 1494.
Sirakov, M., Claret, L., & Plateroti, M. (2021). Thyroid Hormone Nuclear Receptor TRα1 and Canonical WNT Pathway Cross-Regulation in Normal Intestine and Cancer. Frontiers in Endocrinology, 12, 725708.
Gourain, V., Duluc, I., Domon-Dell, C., & Freund, J.-N. (2021). A Core Response to the CDX2 Homeoprotein During Development and in Pathologies. Frontiers in Genetics, 12, 744165.